zinc oxide has been researched along with Genital Herpes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adelung, R; Agelidis, A; Koujah, L; Mishra, YK; Shukla, D; Suryawanshi, R; Yadavalli, T | 1 |
Adelung, R; Antoine, TE; Bhattacharya, P; Haddad, C; Hadigal, SR; Mishra, YK; Prabhakar, BS; Shukla, D; Valyi-Nagy, T; Yakoub, AM | 1 |
Shukla, D; Yadavalli, T | 1 |
3 other study(ies) available for zinc oxide and Genital Herpes
Article | Year |
---|---|
An Intra-Vaginal Zinc Oxide Tetrapod Nanoparticles (ZOTEN) and Genital Herpesvirus Cocktail Can Provide a Novel Platform for Live Virus Vaccine.
Topics: Administration, Intravaginal; Animals; Female; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus Vaccines; Mice; Nanoparticles; Zinc Oxide | 2019 |
Intravaginal Zinc Oxide Tetrapod Nanoparticles as Novel Immunoprotective Agents against Genital Herpes.
Topics: Animals; Cells, Cultured; Chlorocebus aethiops; Female; HeLa Cells; Herpes Genitalis; Herpesvirus 2, Human; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Structure-Activity Relationship; Vero Cells; Zinc Oxide | 2016 |
Could zinc oxide tetrapod nanoparticles be used as an effective immunotherapy against HSV-2?
Topics: Animals; Antiviral Agents; Cell Line; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus Vaccines; Humans; Immunotherapy; Metal Nanoparticles; Surface Properties; Vaccination; Zinc Oxide | 2016 |